Risk Minimisation Materials

Bayer Intrauterine System (IUS) Educational Pack

Healthcare professional brochure to describe risk of ectopic pregnancy and how to differentiate between Bayer levonorgestrel IUS (LNG-IUS)

For Healthcare Professionals

Patient Information Booklet

Information to patients about the treatment with JETREA® (ocriplasmin 0.375 mg/ 0.3 mL solution for injection)

Jext® Expiry Alert

This product has additional materials to help ensure that your Jext® is always within the expiry date.

Jext® Video Demonstration

This product has downloadable videos available to ensure that you know when and how to use Jext® correctly.

JINARC UK aRMM - Healthcare professionals (HCPs) Educational Guide

Jinarc is a specialist product and additional training is required prior to prescribing. Please visit https://www.jinarctraining.co.uk/ to register and complete the training. Training must be completed prior to prescribing Jinarc. This guide has been developed for prescribers and healthcare professionals (HCPs) involved in the treatment of patients using Jinarc (tolvaptan). This document summarises important information on the potential risk of hepatic toxicity and provides guidance on how to manage this risk. In addition, it provides important information about pregnancy prevention before and during the treatment with Jinarc.

For Healthcare Professionals

JINARC UK aRMM - Patient Alert Card

Jinarc is a specialist product and additional training is required prior to prescribing. Please visit https://www.jinarctraining.co.uk/ to register and complete the training. Training must be completed prior to prescribing Jinarc. This patient alert card should be used by patients who have been prescribed medicines containing tolvaptan, and should carry with them at all times when taking this medicine. This card contains important safety information that patient needs to be aware of before, during, and after treatment with Jinarc (tolvaptan).

JINARC UK aRMM - Patient/Carer Education Brochure

Jinarc is a specialist product and additional training is required prior to prescribing. Please visit https://www.jinarctraining.co.uk/ to register and complete the training. Training must be completed prior to prescribing Jinarc. The guide should be provided to patients by the prescribing physician and includes a description of the risks of treatment, guidance on what to do in the event of risks occurring and an overview of treatment monitoring.

Combined hormonal contraceptives: Checklist for Prescribers

Combined hormonal contraceptives: Checklist for Prescribers

For Healthcare Professionals

Combined hormonal contraceptives: Important information for women

Combined hormonal contraceptives: Important information for women

Combined hormonal contraceptives: Important information for women about the risk of blood clots

Combined hormonal contraceptives: Important information for women about the risk of blood clots

Jylamvo (methotrexate) – Patient Card - Risk Minimisation Information for Patients

The Patient Card contains important safety information the patient needs to be aware of when receiving treatment with Jylamvo (methotrexate).

Jylamvo (methotrexate) oral solution - Guide for Healthcare Professionals

This Jylamvo (methotrexate) healthcare professional guide includes important information to minimise the risk of medication error

For Healthcare Professionals

Jyseleca HCP Guide

Jyseleca Healthcare Professionals Guide - for HCPs only

For Healthcare Professionals

Jyseleca Patient Alert Card

Jyseleca Patient Alert Card